Session & Updates

Keynote Address
Janet Woodcock, FDA, MD

Keynote Address

Peter Kim, Merck Research Laboratories, PA

SESSIONS:

• Advancing Risk Assessment Approaches in the 21st Century
• Recent Successes and Future Challenges in Accelerating Implementation of the NRC Tox 21 Report
• Patient Risk Assessment Based on Carcinogenicity Evaluation of Pharmaceuticals 
• Irradiation in the Production, Processing and Handling of Food: The U.S. Framework
• Threshold of Toxicological Concern: Designs, Domains, and Databases
• Improving our Understanding of the Cancer Risk Posed by Hexavalent Chromium in Drinking Water
• When Epidemiology and Toxicology Collide: Navigating the Path Forward for Formaldehyde
• Use of New Data on the Former Fuel Additive, MTBE,  in Hazard Identification and Risk Assessment

UPDATES:

• NTP Workshop: Role of Environmental Chemicals in the Development of Diabetes and Obesity
• FDA’s Guidance for Industry on Reproductive and Developmental Toxicities
• The ELSIE Database: Extractable, Leachable and Knowledge Sharing Amongst  Pharmaceutical Companies and Regulators
• FDA’s Dietary Supplements Office: New Director/New Directions
• FDA’s Medical Countermeasures (MCM) Initiative: Responding Faster and More Effectively toBioterrorism and Infectious Diseases
• A Therapeutic Intervention that Mitigates Intestinal Acute Radiation Poisoning
• Protecting the U.S. Food Supply from Foods Contaminated with Radionuclides From a Nuclear Reactor Accident?